These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 24972450

  • 41. Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications.
    Gou HF, Chen XC, Zhu J, Jiang M, Yang Y, Cao D, Hou M.
    J Exp Clin Cancer Res; 2011 Jan 28; 30(1):14. PubMed ID: 21272377
    [Abstract] [Full Text] [Related]

  • 42. PDGF-BB/KLF4/VEGF Signaling Axis in Pulmonary Artery Endothelial Cell Angiogenesis.
    Liang S, Yu H, Chen X, Shen T, Cui Z, Si G, Zhang J, Cheng Y, Jia S, Song S, Zhang X, Yu X.
    Cell Physiol Biochem; 2017 Jan 28; 41(6):2333-2349. PubMed ID: 28478450
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, Fu S, Zhang Y, Feng K, Feng Y.
    Eur J Cancer; 2014 Sep 28; 50(13):2336-50. PubMed ID: 25001183
    [Abstract] [Full Text] [Related]

  • 45. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
    Špirić Z, Eri Ž, Erić M.
    Int J Surg Pathol; 2015 Dec 28; 23(8):629-37. PubMed ID: 25911567
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH, Huang DP, Guo GL, Chen GR, Zhang HX, Wan L, Chen SY.
    BMC Cancer; 2008 Jan 13; 8():4. PubMed ID: 18190720
    [Abstract] [Full Text] [Related]

  • 48. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
    Donnem T, Al-Shibli K, Al-Saad S, Busund LT, Bremnes RM.
    J Thorac Oncol; 2009 May 13; 4(5):578-85. PubMed ID: 19318994
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer.
    Jia YT, Li ZX, He YT, Liang W, Yang HC, Ma HJ.
    World J Gastroenterol; 2004 Nov 15; 10(22):3261-3. PubMed ID: 15484296
    [Abstract] [Full Text] [Related]

  • 52. The association of VEGF-C expression with tumor lymphatic vessel density and lymph node metastasis in patients with gastric cancer and gastrointestinal stromal tumor.
    Kigure W, Fujii T, Sutoh T, Morita H, Katoh T, Yajima RN, Yamaguchi S, Tsutsumi S, Asao T, Kuwano H.
    Hepatogastroenterology; 2013 Nov 15; 60(122):277-80. PubMed ID: 23574654
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Relation of lymphatic microvessel density detected by monoclonal antibody D2-40 with VEGF-C expression in breast cancer].
    Xie XD, Qu SX, Zheng ZD, Song FL, Liu DW.
    Zhonghua Zhong Liu Za Zhi; 2008 May 15; 30(5):356-60. PubMed ID: 18953835
    [Abstract] [Full Text] [Related]

  • 55. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.
    Suzuki S, Dobashi Y, Hatakeyama Y, Tajiri R, Fujimura T, Heldin CH, Ooi A.
    BMC Cancer; 2010 Nov 30; 10():659. PubMed ID: 21118571
    [Abstract] [Full Text] [Related]

  • 56. Lymphangiogenesis in gastric carcinoma correlates with prognosis.
    Gao P, Zhou GY, Zhang QH, Su ZX, Zhang TG, Xiang L, Wang Y, Zhang SL, Mu K.
    J Pathol; 2009 Jun 30; 218(2):192-200. PubMed ID: 19224540
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Vascular endothelial growth factors C and D and lymphangiogenesis at the early stage of esophageal squamous cell carcinoma progression.
    Kumagai Y, Tachikawa T, Higashi M, Sobajima J, Takahashi A, Amano K, Fukuchi M, Ishibashi K, Mochiki E, Yakabi K, Tamaru J, Ishida H.
    Dis Esophagus; 2018 Aug 01; 31(8):. PubMed ID: 29800478
    [Abstract] [Full Text] [Related]

  • 59. PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer.
    Ming J, Liu N, Gu Y, Qiu X, Wang EH.
    Pathology; 2009 Feb 01; 41(2):118-26. PubMed ID: 19152186
    [Abstract] [Full Text] [Related]

  • 60. Labeling of microvessel density, lymphatic vessel density and potential role of proangiogenic and lymphangiogenic factors as a predictive/prognostic factors after radiotherapy in patients with cervical cancer.
    Biedka M, Makarewicz R, Marszałek A, Sir J, Kardymowicz H, Goralewska A.
    Eur J Gynaecol Oncol; 2012 Feb 01; 33(4):399-405. PubMed ID: 23091898
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.